Zobrazeno 1 - 10
of 984
pro vyhledávání: '"ahus"'
Autor:
Yoshitaka Tatematsu, Takahiro Imaizumi, Nobuaki Michihata, Noritoshi Kato, Ryosuke Kumazawa, Hiroki Matsui, Kiyohide Fushimi, Hideo Yasunaga, Shoichi Maruyama
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Atypical haemolytic uremic syndrome (aHUS) is a rare disorder characterised by complement-mediated thrombotic microangiopathy (TMA). Despite clinical guidelines, the diagnosis and treatment of aHUS in its early stages remains challenging. Th
Externí odkaz:
https://doaj.org/article/87308da8e3544269b6ee9fd6e8912eae
Autor:
Michal Nowicki, Nikoleta Printza
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 13, Iss 11 (2024)
This summary gives an overview of three published articles that report the results of research studies of ravulizumab, an approved treatment for people with atypical hemolytic uremic syndrome (often shortened to aHUS). This is a rare and serious c
Externí odkaz:
https://doaj.org/article/4472bc33e4da435a92f5fdf66a2f6cb5
Publikováno v:
Kidney Medicine, Vol 6, Iss 10, Pp 100892- (2024)
Rationale & Objective: Postpartum renal cortical necrosis (postpartum RCN) is a severe form of obstetric acute kidney injury. This study aimed to identify clinicopathologic features in Chinese postpartum RCN cases to determine how pathologic findings
Externí odkaz:
https://doaj.org/article/f1cd31c8179f4d568b2fcc5d9eaff36a
Publikováno v:
Frontiers in Pediatrics, Vol 12 (2024)
Eculizumab, a recombined humanized monoclonal antibody which possesses high affinity for the complement protein C5, is a therapeutic agent utilized in the treatment of atypical hemolytic uremic syndrome (aHUS) by inhibiting the terminal complement co
Externí odkaz:
https://doaj.org/article/887a274c3e0f46f189e0ba4b6902a927
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Alex Domínguez-Vargas, Fanny Ariño, Diana Silva, Henry J. González-Tórres, Gustavo Aroca-Martinez, Eduardo Egea, Carlos G. Musso
Publikováno v:
American Journal of Perinatology Reports, Vol 14, Iss 01, Pp e96-e100 (2024)
Pregnancy-associated atypical hemolytic uremic syndrome (P-aHUS) is a rare condition characterized by microangiopathic hemolytic anemia and kidney injury from thrombotic microangiopathy. P-aHUS occurs in approximately 1 in 25,000 pregnancies and is s
Externí odkaz:
https://doaj.org/article/3174f61c57b24856bacdbeb50b432447
Autor:
Teri J Mauch, Michael R Chladek, Spero Cataland, Shruti Chaturvedi, Bradley P Dixon, Katherine Garlo, Anuja Java, Jorge Leguizamo, Lucy Lloyd-Price, Tan P Pham, Tara Symonds, Ioannis Tomazos, Yan Wang
Publikováno v:
Journal of Comparative Effectiveness Research (2023)
Aim: Ravulizumab and eculizumab are complement C5 inhibitors approved for the treatment of atypical hemolytic uremic syndrome (aHUS). Ravulizumab requires less frequent infusions than eculizumab, which may reduce treatment burden. This study invest
Externí odkaz:
https://doaj.org/article/b3671b5eba764e1c87aabb550deb1f3f
Autor:
Natalja Haninger-Vacariu, Andreas Gleiss, Martina Gaggl, Christof Aigner, Renate Kain, Zoltán Prohászka, Ágnes Szilágyi, Dorottya Csuka, Georg A. Böhmig, Raute Sunder-Plassmann, Gere Sunder-Plassmann, Alice Schmidt
Publikováno v:
Kidney Medicine, Vol 5, Iss 7, Pp 100669- (2023)
Rationale & Objective: Pregnancy, delivery, and neonatal outcomes in women with complement-mediated thrombotic microangiopathy (cTMA) have not been well described. A better understanding of these outcomes is necessary to provide women with competent
Externí odkaz:
https://doaj.org/article/51751ebe3aee44e490aa91cc12166e20
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.